Does a defect of energy metabolism in the nerve fiber underlie axonal degeneration in polyneuropathies?
- 1 June 1979
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 5 (6) , 501-507
- https://doi.org/10.1002/ana.410050602
Abstract
A number of chemically unrelated neurotoxic compounds and several types f metabolic abnormalities cause strikingly similar patterns of distal symmetrical polyneuropathy in humans and animals. Experimental studies with laboratory species have demonstrated that many toxic polyneuropathies are associated with distal and retrograde axonal degeneration occurring in vulnerable nerve fiber tracts in the central as well as the peripheral nervous system. This has been termed central-peripheral distal axonopathy. Recent observations from the authors' laboratories regarding (1) the spatial-temporal evolution of nerve fiber degeneration in experimental toxic neuropathies and (2) the inhibition of glycolytic enzymes by chemically unrelated neurotoxic compounds point to a common metabolic basis for many distal axonopathies. It is postulated that neurotoxic compounds deplete energy supplies in the axon by inhiniting nerve fiber enzymes required for the maintenance of energy synthesis. Resupply of enzymes from the neuronal soma fails to meet the increased demand for enzyme replacement in the axon, causing the concentration of enzymes to drop in distal regions. This leads to a local blockade of energy-dependent axonal transport, which produces a series of pathological changes culminating in distal nerve fiber degeneration. The idea provides a working hypothesis with which to study the cause of inherited and acquired human and animal polyneuropathies.Keywords
This publication has 26 references indexed in Scilit:
- Slow Axonal Transport of Neurofilament Proteins: Impairment of β,β′-Iminodipropionitrile AdministrationScience, 1978
- MECHANISMS INVOLVED IN THE ‘DYING-BACK’ PROCESS—AN HYPOTHESIS IMPLICATING COENZYMESNeuropathology and Applied Neurobiology, 1977
- Characterization of the metabolites of methyl n-butyl ketone, methyl iso-butyl ketone, and methyl ethyl ketone in guinea pig serum and their clearanceToxicology and Applied Pharmacology, 1976
- DEGENERATION IN CENTRAL AND PERIPHERAL NERVOUS SYSTEMS PRODUCED BY PURE n-HEXANE: AN EXPERIMENTAL STUDYBrain, 1976
- Experimental neuropathy produced by 2,5-hexanedione--a major metabolite of the neurotoxic industrial solvent methyl n-butyl ketone.Journal of Neurology, Neurosurgery & Psychiatry, 1975
- Peripheral neuropathy associated with inhalation of methyl-n-butyl ketoneCellular and Molecular Life Sciences, 1974
- Toxic Polyneuropathy Produced by Methyl N -Butyl KetoneScience, 1974
- Profile of volatile metabolites in urine by gas chromatography-mass spectrometryAnalytical Chemistry, 1973
- RELATION OF ATP AND CREATINE PHOSPHATE TO FAST AXOPLASMIC TRANSPORT IN MAMMALIAN NERVE1Journal of Neurochemistry, 1972
- INHIBITION OF GLYCERALDEHYDE‐3‐PHOSPHATE DEHYDROGENASE IN MAMMALIAN NERVE BY IODOACETIC ACIDJournal of Neurochemistry, 1971